Effets immunomodulateurs des immunoglobulines intraveineuses au cours des maladies auto-immunesImmunomodulatory effects of intravenous immunoglobulins (IVIg) in autoimmune diseases abstract
Références (46)
- et al.
Effect of intravenous immunoglobulin in immune thrombocytopenia. Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells?
Lancet
(1983) - et al.
Infusion of Fcg fragments for the treatment of children with acute immune thrombocytopenic purpura
Lancet
(1993) - et al.
Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous immunoglobulins
Blood
(1989) - et al.
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
Blood
(1989) - et al.
Endothelial cell activation of high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
Lancet
(1989) - et al.
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
Blood
(1994) - et al.
Kawasaki Syndrome
Curr Prob Pediat
(1991) - et al.
Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg)
Clin Immunol Immunopathol
(1994) - et al.
A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines an idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg)
J Autoimmun
(1990) - et al.
Monoclonal anti-idiotypic antibodies against human anti-thyroglobulin autoantibodies recognize idiotopes shared by disease-associated and natural anti-thyroglobulin autoantibodies
Clin Immunol Immunopathol
(1993)
Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillary levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient
Ann Inst Pasteur Immunol
(1983)
Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg)
Blood
(1992)
Intravenous immune globulin therapy for neurologic diseases
Ann Int Med
(1997)
Manipulating the immune system with immune globulin
New Engl J Med
(1992)
Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin
New Engl J Med
(1982)
Modulation of mononuclear phagocyte function by intravenous gamma globulin
J Immunol
(1984)
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody
New Engl J Med
(1986)
Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model
J Clin Invest
(1989)
In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration
Int Arch Allergy Appl Immunol
(1986)
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complements fragments
J Clin Inv
(1994)
Down-regulation of cytokine production and IL-2 receptor expression by pooled human IgG
Immunology
(1993)
Suppression of cytokine-dependant human T-cell proliferation by intravenous immunoglobulin
Clin Immunol Immunopathol
(1994)
Intravenous immunoglobulin induces interferon-g and interleukin-6 in vivo
J Clin Immunol
(1993)
Cited by (0)
Copyright © 1999 Published by Elsevier Masson SAS